Compare GRMN & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRMN | TEVA |
|---|---|---|
| Founded | 1990 | 1901 |
| Country | Switzerland | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.4B | 49.5B |
| IPO Year | 2000 | 1996 |
| Metric | GRMN | TEVA |
|---|---|---|
| Price | $283.71 | $44.37 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 15 |
| Target Price | ★ $299.00 | $49.44 |
| AVG Volume (30 Days) | 786.1K | ★ 6.3M |
| Earning Date | 10-28-2026 | 11-03-2026 |
| Dividend Yield | ★ 1.47% | N/A |
| EPS Growth | 17.67 | ★ 183.45 |
| EPS | ★ 7.69 | 0.02 |
| Revenue | ★ $7,245,519,000.00 | N/A |
| Revenue This Year | $12.46 | N/A |
| Revenue Next Year | $12.13 | $3.42 |
| P/E Ratio | ★ $37.41 | $2,185.50 |
| Revenue Growth | ★ 15.06 | N/A |
| 52 Week Low | $186.67 | $24.01 |
| 52 Week High | $314.28 | $44.31 |
| Indicator | GRMN | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 49.46 | 69.39 |
| Support Level | $266.72 | $38.55 |
| Resistance Level | $297.31 | N/A |
| Average True Range (ATR) | 10.33 | 1.21 |
| MACD | 0.47 | 0.23 |
| Stochastic Oscillator | 58.76 | 98.60 |
Garmin produces GPS-enabled hardware and software for five sectors: fitness, outdoors, automotive, aviation, and marine. Garmin has built a strong reputation for durable, high-precision devices through a vertically integrated design and manufacturing approach. The company's product lines include smartwatches, fitness trackers, communication equipment, and a comprehensive suite of systems for marine and aviation navigation. Garmin operates globally, with its business focused primarily on North America and Europe.
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.